ࡱ> q` R>ybjbjqPqP::$'*    77787d(8 9 9(H9H9H9C;C;C;=??????$h8cQ#E;@C;#E#Ec  H9H9SLSLSL#E~ .H9H9=SL#E=SLSLU2բH99 0Rbv7I)N)ʦ0w^0kJ~0բ0բTC;3=bSL>?rC;C;C;ccKjC;C;C;#E#E#E#E%55        Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limited(a joint stock company established in the People s Republic of China with limited liability)(Stock Code: 0719)CONTINUING CONNECTED TRANSACTIONSummaryReference is made to the announcement of the Company dated 23 October 2008 and the circular of the Company dated 5 November 2008. Continuing connected transaction between the Company and L. PerrigoThe Board announces that on 28 October 2010, the Company and L. Perrigo entered into the Perrigo Agreement in relation to the Company supplying pharmaceutical products to L. Perrigo and/or its affiliates for a period of two years from 1 January 2011 to 31 December 2012, which is automatically renewable for a term of one year, unless terminated on six months written notice. As at the date of this announcement, L. Perrigo is a subsidiary of Perrigo Company. Perrigo Company is a connected person of the Company as it is the parent company of Perrigo International, which is a substantial shareholder of Xinhua Perrigo, a 50.1% owned subsidiary of the Company. Accordingly, L. Perrigo, being a subsidiary of Perrigo Company, is also a connected person of the Company and the transactions contemplated under the Perrigo Agreement will constitute a continuing connected transaction under Chapter 14A of the Listing Rules.The highest annual cap for 2011, 2012 and 2013 under the Perrigo Agreement is RMB70,000,000. The applicable percentage ratios (as defined in the Listing Rules) are less than 5% on an annual basis. In accordance with rule 14A.34 of the Listing Rules, the continuing connected transaction is only subject to the reporting and announcement requirements as described in rules 14A.45 to 14A.47 of the Listing Rules, the annual review requirements set out in rules 14A.37 to 14A.40 of the Listing Rules and the requirements set out in rules 14A.35(1) and 14A.35(2) of the Listing Rules. The continuing connected transaction is exempt from the independent shareholders approval requirements.Background InformationThe Company entered into an agreement with L. Perrigo on 7 October 2008 in relation to the Company supplying the pharmaceutical products to L. Perrigo and/or its affiliates for a period of three years from 1 January 2008 to 31 December 2010. An announcement was made on 23 October 2008. As the above agreement will expire on 31 December 2010, in order to secure the orders from L. Perrigo and/or its affiliates in the future, the Company has entered into the Perrigo Agreement with L. Perrigo for a period of two years commencing from 1 January 2011 which is automatically renewable for a term of one year, unless terminated on six months written notice.Continuing connected transaction between the Company and L. PerrigoPerrigo AgreementDate : 28 October 2010Parties : (i) the Company (ii) L. PerrigoPrincipal terms and conditionsOn 28 October 2010, the Company and L. Perrigo entered into the Perrigo Agreement in relation to the Company supplying the pharmaceutical products to L. Perrigo and/or its affiliates, including Perrigo Company.The term of the Perrigo Agreement runs from 1 January 2011 to 31 December 2012 and is automatically renewable for a term of one year unless terminated on six months written notice.Payment termsThe price of the pharmaceutical products is based on market prices.L. Perrigo shall pay the Company within 60 days after invoicing. Proposed annual capsThe proposed annual caps for the Perrigo Agreement are as follows:-2011(RMB 000)2012(RMB 000)2013*(RMB 000)Proposed annual caps60,00065,00070,000*if the Perrigo Agreement is renewedThe Company has determined the above annual caps based on the following factors:-the historical figures in 2008, 2009 and January to August 2010 for the transactions between the Company and L. Perrigo and/or its affiliates (please see Table 1 below); the demand by L. Perrigo and/or its affiliates; andthe increase in the market prices of chemical raw materials for the production of the pharmaceutical products (please see Table 2 below). Table 1- Historical figures in 2008, 2009 and January to August 2010 for the transactions between the Company and L. Perrigo and/or its affiliates2008 (RMB000)2009(RMB000)January to August 2010(RMB000)Total consideration39,70934,77514,573Table 2 Approximate market prices of chemical raw materials2009January to August 2010IsobutylbenzeneRMB13,600 per tonRMB15,000 per tonNeopentyl glycolRMB8,900 per tonRMB13,600 per tonPetroleum benzinRMB4,900 per tonRMB6,400 per tonReasons for and benefits of the continuing connected transaction between the Company and L. PerrigoBy selling the pharmaceutical products to L. Perrigo, the Company is able to expand its business in the United States. Accordingly, the Directors (including the independent non-executive Directors) consider that:the entering into the Perrigo Agreement is in the best interest of the Company and its Shareholders as a whole; the transactions contemplated under the Perrigo Agreement are on normal commercial terms and in the ordinary and usual course of business; and the terms of the transactions under the Perrigo Agreement are fair and reasonable.As far as the Company is aware, no Director has a material interest in the transaction and therefore no Director is required to abstain from voting on the board resolution in relation to the transaction. Connected RelationshipAs at the date of this announcement, L. Perrigo is a subsidiary of Perrigo Company. Perrigo Company is a connected person of the Company as it is the parent company of Perrigo International, which is a substantial shareholder of Xinhua Perrigo, a 50.1% owned subsidiary of the Company. Accordingly, L. Perrigo, being a subsidiary of Perrigo Company, is also a connected person of the Company and the transactions contemplated under the Perrigo Agreement constitute a continuing connected transaction under Chapter 14A of the Listing Rules.Implications under the Listing RulesThe highest annual cap for 2011, 2012 and 2013 under the Perrigo Agreement is RMB70,000,000. The applicable percentage ratios (as defined in the Listing Rules) are less than 5% on an annual basis. In accordance with rule 14A.34 of the Listing Rules, the continuing connected transaction is only subject to the reporting and announcement requirements as described in rules 14A.45 to 14A.47 of the Listing Rules, the annual review requirements set out in rules 14A.37 to 14A.40 of the Listing Rules and the requirements set out in rules 14A.35(1) and 14A.35(2) of the Listing Rules. The continuing connected transaction is exempt from the independent shareholders approval requirements.Information about the Company and L. PerrigoThe Company is mainly engaged in the development, manufacture and sales of bulk pharmaceuticals, preparations and chemicals products.L. Perrigo is principally engaged in the manufacture, distribution and sale of certain over-the-counter, non-prescription pharmaceutical products in the United States. DEFINITIONSIn this announcement, the following expressions have the meanings set out below unless the context requires otherwise:Boardmeans the board of Directors of the Company;Company means q\qge兡N gPlQS (Shandong Xinhua Pharmaceutical Company Limited), a joint stock company incorporated in the PRC with limited liability; Directors means the directors of the Company; Hong Kong means Hong Kong Special Administrative Region of the PRC;HK$means Hong Kong dollars, the lawful currency of Hong Kong;L. Perrigomeans L. Perrigo Company, a company established in the United States; Listing Rulesmeans the Rules Governing the Listing of Securities on the Stock Exchange;Perrigo Agreementmeans the written agreement entered into between the Company and L. Perrigo dated 28 October 2010;Perrigo Companymeans Perrigo Company, a company established in the United States;Perrigo Internationalmeans Perrigo International, Inc., a company established in the United States and a subsidiary of Perrigo Company;PRC means the Peoples Republic of China;RMB means Renminbi, the lawful currency of the PRC for the time being;Shareholdersmeans the shareholders of the Company; Stock Exchange means The Stock Exchange of Hong Kong Limited;Xinhua Perrigomeans7d e z { | }   x 4 Z \ ^ м{rh]P]hCJOJPJQJo(hKHnHo(tHhyhCJo(hyCJPJo(hCJPJo( h6]hCJo(hnHo(tHh6]o( ho('jh6U]mHnHo(tHuhKHaJh6KH]aJo(h6KH]aJh6KH]aJnHo(tH(jh6KHU]aJmHnHu { } ~   x 2 4 Z \ ] $If$$7$8$H$Ifa$$If$$7$8$G$H$IfVDw^a$$G$H$a$G$H$$G$H$a$G$H$ $7$8$G$H$a$xx?>r"ru ,eϳϳϩϳϳϚhCJOJPJQJaJo(hPJnHtHhPJnHo(tHhKHaJnHo(tHh ho(hnHtHh5KH\nHo(tHhnHo(tHh>*OJPJQJo(<] ^ ?@$$7$8$G$H$Ifa$$7$7$8$H$If^7a$$7$7$8$G$H$If^7a$$$7$8$G$H$Ifa$gdH$$7$8$H$Ifa$$$7$8$G$H$Ifa$gdH $$G$H$Ifa$   +,zzzg\ $7$8$G$H$a$$77$8$G$H$^7a$$7^7a$7^7 & F#77G$^7`G$[kd$$Ifq!!064 qa e;IXbjlm  >HM]θvmhOJQJo(hPJaJo(hnHtHh5\o(hKHo(h5KH\o(hKHnHtHh5KH\nHo(tHhKHnHo(tHhPJnHo(tHhPJo(hCJOJPJQJaJo(hKHaJo(h ho(hnHo(tH)*+=>]^12$77$8$^7 $7G$H$^7a$$7$8$G$H$^a$$7$8$G$H$^a$$77$8$G$H$^7a$$77$8$G$H$^7a$$77$8$G$H$^7a$<=$$7$8$G$H$Ifa$$$7$8$G$H$Ifa$$87$8$G$H$^8a$$7d^7`$77$8$G$H$^7a$$77$8$G$H$^7a$$ & F nn7$8$G$H$^n`a$ #%*,139_` _lop %?EǼǼǯthKHPJaJnHo(tHhKHaJnHtHhKHaJo(haJo(h5KH\aJnHo(tHhKHaJnHo(tHhPJnHo(tHhnHo(tHh5\mHnHo(tHuh5\o(h5\nHtHh5\nHo(tH-#*18k\MMM$$7$8$G$H$Ifa$$$7$8$G$H$Ifa$kd$$Ifq\l! TT5064qa89:_`kTEE?98^87^7$77$8$G$H$^7a$$\7$8$G$H$VDWDQ^`\a$kdF$$Ifq\l! TT5064qa^_ mZ$T$7$8$G$H$Ifa$$T$7$8$G$H$If^a$$T7$8$G$H$^a$$77$8$G$H$^7a$$T7$8$G$H$a$$887$8$G$H$^8`a$$887$8$G$H$^8`a$$ & F nn7$8$G$H$^n`a$ E`b  !)*`ay{~Ѷ݀򶧶ݚzzݚzz hKHhKHaJ#h5KHPJ\aJnHo(tHhKHPJnHo(tHh5KH\aJnHtHh5KH\aJnHo(tHh5KH\aJh5KH\aJo(hKHaJo(hKHaJnHtHhKHaJnHo(tH0 O8$T$7$8$G$H$If^a$kd$$Ifq4\ H! T 064 qa$T$7$8$G$H$Ifa$  :kd$$Ifq"\ H! T 064 qa$T$7$8$G$H$Ifa$$T$7$8$G$H$If^a$ !_`afg~$T$7$8$G$H$Ifa$$T$7$8$G$H$If^a$$\7$8$G$H$VDWDQ^`\a$ $7$8$G$H$a$u^GG$T$7$8$G$H$If^a$$T$7$8$G$H$If^a$kd$$Ifq4F 4!   06    4 qaw`II$T$7$8$G$H$If^a$$T$7$8$G$H$If^a$kdy$$Ifq"F 4!   06    4 qa'+ ?幩pcZhPAKHaJo(hKHaJnHo(tHhKHPJaJnHo(tHhKHaJhKHaJnHo(tHhKHaJo(h5KH\aJo(h5KH\aJnHo(tH)hh5KHPJ\aJnHo(tH hKHhKHaJo(hKHaJhKHaJnHo(tHhKHPJnHo(tH w`II$T$7$8$G$H$If^a$$T$7$8$G$H$If^a$kd<$$Ifq"F 4!   06    4 qaYwiZE2$77$8$G$H$^7a$$7$8$G$H$VD^`a$$77$8$G$H$^7a$$7$8$G$H$a$gdkd$$Ifq"F 4!   06    4 qa?@IJXYZlpx UVW[\]af˼ˡˡˡˡˡˡ}m`ˡˡUhPJnHo(tHhs{KHaJnHo(tHhs{hKHaJnHo(tHh`=KHPJaJnHo(tHhs{KHaJo(hs{hKHaJo(hKHaJo(#hs{hs{KHPJaJnHo(tHhKHPJaJnHo(tHhKHaJnHo(tHhRKHPJaJnHo(tHhPAKHaJo(hPAKHPJaJnHo(tH YZ\]~  """"$7d^7`$77$8$G$H$^7a$$ & F$7$8$G$H$a$$77$8$G$H$^7a$gds{$ & F$7$8$G$H$a$gd`=$77$8$G$H$^7a$~  '!*!@!U!]!!!!!i"k""""",#.#{#####$t$$$%%"%$%H%q%r%%%%%%%%ƽӫ㽸㸴㸒ۆ}hKHaJo(h5KH\aJo(hKHPJaJnHo(tHhPJnHtHhOJQJo(h ho(hnHo(tHhKHaJnHo(tHhnHtHh5\o(hPJnHo(tH"hB*PJaJnHo(phtH0"%%%%?&@&&&&&n'o'w'x' $7$8$G$H$If7$8$G$H$ & F#77G$^7` $7$8$G$H$a$$7d^7` 7$8$H$VD^$77$8$H$^7a$$77$8$G$H$^7a$$7$8$G$H$VD^a$%%%%&&&>&?&@&&&&&&&&M'N'm'o'w'}''''$(F(H((())0)<)v)~)))**µsmfmfmfmfmfmfmfmfmfmfmfmfhKHo( hKHh5KH\aJo(hCJOJPJQJaJo(hCJOJPJQJaJhKHPJnHo(tHhKHaJnHtHhKHaJnHo(tHhPJnHo(tHhCJKHOJPJaJo(hKHPJaJo(hKHPJaJnHo(tHhKHPJaJ(x'''')))2)z)LLkd2$$If0 ! 64 a8 $7$8$G$H$IfLkd$$If0 ! 64 a8$$7$8$G$H$Ifa$z)|)~))****H*LLkd$$If0 ! 64 a8 $7$8$G$H$IfLkd$$If0 ! 64 a8$$7$8$G$H$Ifa$* **F*J*K*M*N*U*V*s*z**********++u+v+w++++++++2,X,Y,Z,`,f,,,,,,,,,,,---%-M-Q-R-`-a-b-.tt.u4u6u8uujuuuuwwdQ$, 7$8$G$H$^ a$$< 7$8$G$H$^ a$$ 7$8$G$H$^ a$ $7$8$G$H$a$$7$8$G$H$^`a$Lkd $$If0 ! 64 a8$$7$8$G$H$Ifa$ ujuuuuuuuuvvv,v.v0v2vvvvv*wHwZw\whwlwjxvxxxxxxxxxxxxھ匃{{{{{{{sosososohq@jhq@UhnHtHhnHo(tH ho(hKHaJnHo(tHhKHaJo(h6KH]aJh6KH]aJo(h5KH\aJnHo(tHh5KH\aJo(h5KH\aJhKHaJ#hhKHPJaJnHo(tH'uu.v0v2vvvvw,wHwjwlwwww*x,x.xGkdR$$If0!64 a $$G$Ifa$$G$a$ $7$8$G$H$a$.xbxxxxxxxxxxxxxxxxxxx&`#$Gkd$$If0!64 a $$G$Ifa$xxxxxxxxxxxxxxxxxxy ho(hq@hCJo(hR0JmHnHuhh0JmHnHu h0Jjh0JUxxxxxxxxxxxxxxxxyyyyy y yyyy$7$8$H$VDw^a$$4$a$&`#$yyyyyyy y"y$y&y(y*y,y.y0y2y4y6y8y:yy/0P/ =!"#$n% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB*KHPJaJnHtH$A@$ ؞k=W[SOFi@F nfh*KHOJPJQJnHtHhS@h ckee,g)ۏ 3$$7$8$G$H$^a$KHPJWDFnHtH.. yblFhe,gCJaJpOpChar Char Char Chard1$CJKHPJaJmHnHtHu  !"#$%&'()7%_     '   & %!$"##"$!% &'  !"#$%&'(),     !"#$%&'7% {}~-.OPQYZ"#o p q r  d e w x hiwxZ[\alq|23345DISjtu"45FWij{KL0145Z[  89ijvw%&1678>yz{, - . B !!!!!!!!!""""">"?"Q"""""2#3#4#5#6#7#M#|#########$$.$<$M$N$s$$$$$$$$$$$$$$$$$$$$$$$$ % % % %%%%%%%%%%%%%%%%%%%% %!%"%#%$%%%&%'%(%)%*%+%,%-%.%/%0%1%2%3%4%5%8%00000000000000000000000000 0 H0H# 00r 0r 0r 0r 0r H# 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 h0 0i 0i0i 0i0i800000 00 00 00 0 0 0 0 0 0 0000 00 00 00000 0 00 00 0 0 00 0 0 0 00 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0000$ 00$ 00$ 00000008005505050558000H# 000000 0 0 0 00 0 0 00 0 0 00 0 0 00 0 0 00 0 0 00 0 0 00 0 0 00 0 0 00 0 0 00 0 0 00 0 00 0 0 0 00 0 0 00 0 0000000000000000000 00000 0 0000 0 0 0@0I00@0I00@0I00@0I00@0@0@0@0@0@0I00 000000000000000000000000000000000000000000vp q  8%K00v K0 <I0 I0 I00I00K00I00,I00 0I00I00I00;0K00P &&&) eE?%*y $*-/14>A] 8  Y"x'z)H**+,,4uu.xxy>y!"#%&'()+,.02356789=?@BC(  N _ 3 _N  S AB S  ?{7%_|!LtxPt#EcElcEdcEcE cEl cE|$cEBcEtCcƒEbÃE̖băELŃE3cƃE$2cǃE\%cȃED=cɃE5cʃEd/c˃EDc̃E+c̓Etb΃E)cσEDbЃELcуEc҃E;qӃED?qԃE?qՃE?qփE|Wd׃EWd؃EWdكE ll8&0rYYn V!V!!!##8%     !"7A yy;)3uffw c!c!!!##8%  !"8*urn:schemas-microsoft-com:office:smarttagsCityB#*urn:schemas-microsoft-com:office:smarttagscountry-region9"*urn:schemas-microsoft-com:office:smarttagsplace<!*urn:schemas-microsoft-com:office:smarttagschmetcnv k01142008aFalseHasSpaceinNegative NumberType SourceValueTCSCTrueUnitName#"!  !  !  !  !  !  !  !  !  "#!  !   !   !   !   !   !   !   "#"""#"#"#"#"!cj|FMRY   X _ r y \ c e l  %w~7>5>tz18t{ ?FZals FMel077CNT/ 6 !!#!x!!!!""""""""""""#!#V#\##### $$#$&$'$-$2$4$5$;$E$L${$$$$$$$$$$$$$$$$$$$$ % %8%ry1$$$$$$$$$$$$ % %8%3333333-.Ze ixlq|5DSju{jw ""|##$$.$<$$$$$$$$$$$$$$$ % %8%$$$$$$$$$$$$ % %8%$>k/0h{c  u:%M bU^X.` KP $Y[T^T3j s/?!c0 $%̛P& Q.'FFk4C41e$M8NyeW:Xi9AT~ZATΈdDNtT\I\FGKLjE|Lb7Q 'C U8CYR-J^sB`6sRdzke$M8 TiT3j Y[{c 7Q:%M E|Lmw-J^//?!ukxQ.'sRdi9A\IwoB`yeW:P& $%dDZAKP vW~GK$$%        Zn       r        f#h        ’                         x0>b*       oTԚ=      Gi                          f:Ob|       &"N                 :        g0       H{*       U        b        ,:        J         Lr        f6                          X"        tX        H                 Jmwld      6N        }`        *        ܞ        4        Rq@!Zcs{`=E5HPAy` Pp q [\l|45DStu"45FWij{%&178>z{- . B !!!!!!!""">"?"Q""""3#4#|###N$$$$$$8%@"L11"7%p@p p@p(pT@ptUnknown Gz Times New Roman5Symbol3& z ArialC .PMingLiUe0}fԚ;[SOSimSunOTimesLTStd-Roman[SO] Times-BoldTimes New RomanQ MSung-LightPMingLiU_ Times-RomanTimes New Roman 1hff5f dBdB!?!),.:;?]}    " % & ' 2 t%00 0 000000013468:<>@BDOPQRTUVWZ\^ \]d([{  5 0 0 00000579;=?ACY[][d$$  2qHX?`2~The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representationAChan_o(u7b$                           ! " # Oh+'0(4DP\l    The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representationAChanNormal ΢û13Microsoft Office Word@vA@xNe@w-ju@l-Hbvd՜.+,0 X`t|  CharltonsB$   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXY[\]^_`acdefghijklmnopqrstuvwxyz{|}~Root Entry F HRbvData Z1Tableb̭WordDocumentSummaryInformation(DocumentSummaryInformation8CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q